Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DeepKbhb: Context-Aware Prediction of Human Lysine β-Hydroxybutyrylation Sites.

Journal of chemical information and modeling·2026
Same author

Arecoline as a Novel Scaffold Targeting the ATAD2 Bromodomain for Cell Cycle Modulation.

Pharmaceutics·2026
Same author

SiCmiR Atlas: Single-Cell miRNA Landscape Reveals Hub-miRNA and Network Signatures in Human Cancers.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

DeepADR: multimodal prediction of adverse drug reaction frequency by integrating early-stage drug discovery information via Kolmogorov-Arnold networks.

Briefings in bioinformatics·2026
Same author

Integrative Regulatory Networks of MicroRNA-483: Unveiling Its Systematic Role in Human Diseases and Clinical Implications.

Biomolecules·2025
Same author

Semi-inductive dataset construction and framework optimization for practical drug target interaction prediction with ScopeDTI.

Nature communications·2025

Related Experiment Video

Updated: Jul 17, 2026

Cost-Efficient Transcriptomic-Based Drug Screening
06:40

Cost-Efficient Transcriptomic-Based Drug Screening

Published on: February 23, 2024

Transcriptome Inference and Systematic Approaches to Investigate TCM Compounds With Beneficial Metabolic Effects.

Jing Li1,2,3, Yang-Chi-Dung Lin1,2,3, Hsi-Yuan Huang1,2,3

  • 1School of Medicine, the Chinese University of Hong Kong, Shenzhen, Guangdong, PR China.

Phytotherapy Research : PTR
|July 15, 2026
PubMed
Summary

Two traditional Chinese medicine compounds, emodin and triptolide, were identified to combat obesity by enhancing adipose thermogenesis. These compounds boost energy expenditure and reduce fat accumulation, offering potential therapeutic strategies for metabolic disorders.

Keywords:
CMap analysismolecular dockingnetwork pharmacologyobesitytranscriptomic analysistype 2 diabetes mellitus

More Related Videos

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

Related Experiment Videos

Last Updated: Jul 17, 2026

Cost-Efficient Transcriptomic-Based Drug Screening
06:40

Cost-Efficient Transcriptomic-Based Drug Screening

Published on: February 23, 2024

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

Area of Science:

  • Metabolic Health
  • Pharmacology
  • Traditional Chinese Medicine

Background:

  • Obesity is a significant risk factor for type 2 diabetes.
  • Traditional Chinese Medicine (TCM) compounds may improve obesity by increasing energy expenditure.
  • Identifying novel compounds that promote adipose thermogenesis is crucial for obesity management.

Purpose of the Study:

  • To identify and validate TCM compounds that promote adipose thermogenesis for obesity alleviation.
  • To explore the molecular mechanisms underlying the anti-obesity effects of identified TCM compounds.
  • To utilize a multi-omics approach combining transcriptomics, network pharmacology, and CMap analysis.

Main Methods:

  • Transcriptomic analysis of 36 TCMs related to adipose thermogenesis.
  • Network pharmacology and molecular docking for emodin (from Da Huang).
  • Connectivity Map (CMap) analysis to identify triptolide.
  • In vitro (3T3-L1 cells) and in vivo (zebrafish) experimental validation.

Main Results:

  • Emodin and triptolide were identified as potent promoters of adipose thermogenesis.
  • Both compounds increased the NAD+/NADH ratio, activated AMPK and SIRT1, and suppressed lipid accumulation.
  • Upregulation of thermogenesis, lipolysis, mitochondrial biogenesis, and beta-oxidation genes observed.
  • Downregulation of lipogenesis-related genes confirmed anti-obesity effects.

Conclusions:

  • Emodin and triptolide effectively alleviate obesity by enhancing adipose thermogenesis.
  • These compounds modulate key metabolic pathways involved in energy expenditure and lipid metabolism.
  • Combined screening approaches are effective for discovering compounds with beneficial metabolic effects.